Results 31 to 40 of about 35,499 (199)

Efficacy differences of electroacupuncture with single acupoint or matching acupoints for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial

open access: yesTrials, 2017
Background Previous studies have shown that acupuncture is beneficial for the alleviation of chemotherapy-induced nausea and vomiting. However, there is a lack of clinical evidence concerning the effects of acupoint-matching on chemotherapy-induced ...
Bo Chen   +11 more
doaj   +1 more source

Efficacy of acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting in patients with advanced cancer: a multi-center, single-blind, randomized, sham-controlled clinical research

open access: yesChinese Medicine, 2020
Background Chemotherapy-induced nausea and vomiting (CINV) is a common and distressing side effect. We conducted this clinical trial to compare the effectiveness of true acupuncture vs.
Qi-Wei Li   +12 more
doaj   +1 more source

Auricular therapy for chemotherapy-induced nausea and vomiting in cancer patients: Perspectives from the traditional zang-fu organs and meridians theory [PDF]

open access: yes, 2020
This paper presents the theoretical background of using auricular therapy (AT) for managing chemotherapy-induced nausea and vomiting (CINV) from the perspectives of traditional zang-fu organs and meridian theory. The zang-fu organs of stomach, spleen and
Suen, Lorna K., Wang, Tao, Tan, Jing-Yu
core   +1 more source

COMPARISON OF THE ANTIEMETIC EFFECTIVENESS BETWEEN GRANISETRON AND DEXAMETHASONE WITH ONDANSETRON AND DEXAMETHASONE IN ACUTE-PHASE CHEMOTHERAPY PATIENTS

open access: yesFolia Medica Indonesiana, 2017
Nausea and vomiting may occur in patients receiving chemotherapy, a condition referred to as chemotherapy-induced nausea and vomiting. The provision of combined dexamethasone and ondansetron or granisetron is the therapeutic management of acute phase ...
Ria Fitrah Arfiani   +2 more
doaj   +1 more source

The nurse's role in managing chemotherapy-induced nausea and vomiting [PDF]

open access: yes, 2014
Background \ud \ud Nurses play a substantial role in the prevention and management of chemotherapy-induced nausea and vomiting (CINV).\ud \ud Objectives \ud \ud This study set out to describe nurses’ roles in the prevention and management of CINV and to ...
Aranda, Sanchia   +6 more
core   +1 more source

Effect of Aprepitant on Chemotherapy-induced Adverse Reactions in Gynecological Malignancy Patients

open access: yesZhongliu Fangzhi Yanjiu, 2018
Objective To observe the curative effect of aprepitant on chemotherapy-induced nausea and vomiting(CINV) and hemoglobin level in gynecological malignancy patients.
HE Yang   +7 more
doaj   +1 more source

A Qualitative Study to Explore Patient’s experiences on Chemotherapy-induced Nausea and Vomiting: Focusing Impact on Daily Life

open access: yesAsian Pacific Journal of Cancer Care, 2023
Background: This study aimed to explore the experience of cancer patients about chemotherapy-induced nausea and vomiting and its effect on patients’ daily life.
Sushil Gour   +4 more
doaj   +1 more source

Chemotherapy-induced nausea and vomiting: exploring patients’ subjective experience

open access: yes, 2016
Background: This study aimed to explore the subjective experience of nausea and vomiting during chemotherapy treatment among breast cancer patients and the impacts on their daily lives.
Zakaria, Noor Salihah   +2 more
core   +1 more source

Small Intestinal Bacterial Overgrowth Following Gastrointestinal Cancer Surgery: Current Evidence and Future Perspectives

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT Small intestinal bacterial overgrowth (SIBO) has recently gained increasing attention as a potential cause of postoperative gastrointestinal symptoms following gastrointestinal cancer surgery. Surgical procedures can disrupt normal gastrointestinal physiology through anatomical reconstruction, impaired motility, reduced gastric acid secretion,
Toru Aoyama   +2 more
wiley   +1 more source

Cost‐effectiveness of DPYD genotyping prior to fluoropyrimidine‐based treatment for colorectal cancer in Wales

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Background Regulatory guidance in the United Kingdom advises DPYD genotyping prior to fluoropyrimidine‐based treatment. This economic evaluation estimated the costs and outcomes associated with DPYD screening prior to prescribing fluoropyrimidines for colorectal cancer in Wales and also considers additional variants to those included in ...
Catrin O. Plumpton   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy